Mellow Babies - a Pilot Waiting List Trial

Sponsor
University of Aberdeen (Other)
Overall Status
Completed
CT.gov ID
NCT02277301
Collaborator
South Eastern Health and Social Care Trust (Other)
45
1
2
23
2

Study Details

Study Description

Brief Summary

This is a mixed-methods study centred on a prospective randomised openlabel blinded endpoint (PROBE) pilot clinical trial with a waitinglist control group. The study will be conducted in three areas of Northern Ireland: Lisburn, North Down & Ards, and Downpatrick. At least 50 women with infants under 13 months old will be recruited during August/September 2014.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mellow Babies
N/A

Detailed Description

Psychologically informed very early intervention programmes across the ante- and postnatal period have shown promise in delivering cost-effective long term positive outcomes. There is robust support for the view that early intervention to prevent and manage difficulties in the parent-infant relationship may produce long-term benefits such as reduction in rates of criminality, substance abuse and educational underachievement. A meta-analysis of sensitivity and attachment interventions in early childhood has shown that the most effective interventions use a moderate number of sessions (n=5-16) and are focussed on parental sensitivity.

Although Mellow Parenting interventions (Mellow Babies is probably the best-evidenced) are quite widely used in a number of countries, no definitive randomised trials have been carried out. To date there has been a single small waiting list trial suggesting improvement in maternal mood and mother-child interaction, We aim to inform the design of a definitive RCT with a waiting-list control trial with adequate power to estimate an effect size.

This is a parallel randomised open-label blinded end-point (PROBE) clinical trial with a waiting-list control group. The study will be conducted in three areas: Lisburn, North Down & Ards, and Downpatrick. At least 50 women with infants under 18 months old will be recruited in September 2014. Participating women will be given information on the study, in particular being informed that participation would involve either receiving the intervention the following month or after a delay of 20 weeks. Signed consent (which will include consent to follow up after one year, beyond the timespan of this study) will be sought after an interval of at least 24 hours to allow the women to arrive at an informed decision.

Study Design

Study Type:
Interventional
Actual Enrollment :
45 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Mellow Babies - a Pilot Waiting List Trial
Study Start Date :
Aug 1, 2014
Actual Primary Completion Date :
Jul 1, 2016
Actual Study Completion Date :
Jul 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mellow Babies

Mellow Babies is a group day programme, run one day a week over 14 weeks with a joint focus on maternal wellbeing and the parentinfant interaction: transport and crèche facilities are provided.The focus is to: (a) explicitly enhance close mother-infant attunement, using a combination of baby-massage, interaction coaching and infant focussed speech; and (b) offer mothers support for their own distress. Mellow Babies is an intervention designed for mothers with substantial problems in their relationships with their infants. Typically, participating mothers have mental health difficulties, problem drug use, learning difficulties, forensic issues or they may have children already looked after by the local authority.

Behavioral: Mellow Babies
Mellow Babies is an intervention designed for mothers with substantial problems in their relationships with their infants. Typically, participating mothers have mental health difficulties, problem drug use, learning difficulties, forensic issues or they may have children already looked after by the local authority.
Other Names:
  • Mellow Parenting
  • No Intervention: Care as Usual

    Routine care received by mothers with substantial problems in their relationships with their infants. Typically, participating mothers have mental health difficulties, problem drug use, learning difficulties, forensic issues or they may have children already looked after by the local authority.

    Outcome Measures

    Primary Outcome Measures

    1. Mellow Parenting Observation System (MPOS). [16-18 weeks]

      MPOS, is an event sampled observational system in which the rate of positive and negative parenting behaviours is calculated.

    Secondary Outcome Measures

    1. The Adult Wellbeing Scale (Snaith et al 1978) [16-18 weeks]

      The Adult Wellbeing Scale is based on the Hospital Anxiety and Depression Scale which is used to determine the levels of anxiety and depression that a patient is experiencing.

    Other Outcome Measures

    1. The Edinburgh Postnatal Depression Scale (Cox et al 1987) - [16-18 weeks]

      The Edinburgh Postnatal Depression Scale is the standard clinical screening tool for postnatal depression, widely used by health visitors.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    16 Years to 50 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    Mothers of infants aged less then 13 months who have been referred for parenting support by the health or social care services.

    Exclusion Criteria:

    Those unable to complete research assessments (due to literacy or language issues).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Lisburn Health Centre Lisburn United Kingdom BT28 1LU

    Sponsors and Collaborators

    • University of Aberdeen
    • South Eastern Health and Social Care Trust

    Investigators

    • Principal Investigator: Lucy Thompson, BA PhD MPH, University of Aberdeen

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dr Lucy Thompson, Senior Research Fellow, University of Aberdeen
    ClinicalTrials.gov Identifier:
    NCT02277301
    Other Study ID Numbers:
    • 2/033/14
    First Posted:
    Oct 29, 2014
    Last Update Posted:
    Apr 18, 2019
    Last Verified:
    Apr 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Dr Lucy Thompson, Senior Research Fellow, University of Aberdeen

    Study Results

    No Results Posted as of Apr 18, 2019